Evidence map›Paper›PMID 35545307›Full record

ArticleBMJ case reports2022

Muthugaduru Jagadish Deepa, Chitta Megharaj, Santosh Patil, Padmaja Kumari Rani

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. COVID-19 associated with cryptococcosis: a scoping review.Therapeutic advances in infectious disease
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Muthugaduru Jagadish DeepaVitreo-Retina Services, Adarsh Super Speciality Eye Hospital, Shimoga, India.
Chitta MegharajCataract and Refractive Services, Adarsh Super Speciality Eye Hospital, Shimoga, India.
Santosh PatilMicrobiology, Nanjappa Super Speciality Hospital, Shimoga, Karnataka, India.
Padmaja Kumari RaniSmt Kanuri Santhamma Centre for Vitreoretinal Diseases, LV Prasad Eye Institute, Hyderabad, Telangana, India rpk111@gmail.com.ORCID http://orcid.org/0000-0001-7069-8238
L V Prasad Eye Institute · INNethradhama Superspeciality Eye Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A man in mid-50s presented with progressive blurred vision in his left eye for over 6 weeks. He was a known diabetic with history of COVID-19 pneumonia treated with steroids and remdesivir. He had pyelonephritis and urinary culture grown

Indexed as

BasidiomycotaCOVID-19EndophthalmitisEye Infections, BacterialAnti-Bacterial AgentsHumansMaleRetrospective StudiesVitrectomyAnti-Bacterial AgentsCOVID-19CryptococcusEyeInfectionsOphthalmology

Identifiers

PMID35545307
PMCPMC9096502
OpenAlexW4280595500

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.